While the literature specific to chemotherapy and BM remains sparse, several agents, especially those that inhibit the actions of vascular endothelial growth factor (VEGF), have been shown to increase the risk of hemorrhage and other complications in metastatic brain tumors as well as other primary CNS tumors (eg glioblastoma). The gene discussed is VEGFA; the disease is central nervous system neoplasm.